| Combination regimens with statin, niacin, and intestinally active LDL-lowering drugs: alternatives to high-dose statin therapy? | |
| | |
MedLine Citation:
|
PMID: 20625257 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
PURPOSE OF REVIEW: To summarize recent studies on combination regimens that employ a statin with added niacin, ezetimibe, and/or bile acid sequestrants, and to understand the implications of these studies for clinical practice. RECENT FINDINGS: Combinations of statin, niacin, and/or intestinally active LDL-lowering drug have demonstrated safety and favorable effects on plasma low and high-density lipoproteins. Niacin and bile acid sequestrants appear to exert beneficial effects on atherosclerotic lesions, whereas results with ezetimibe are uncertain. Moreover, the use of niacin and bile acid sequestrants is supported by clinical outcome results from large monotherapy trials and small combination therapy trials. Three large randomized trials currently are evaluating clinical outcomes with the addition of niacin or ezetimibe to statin treatment. SUMMARY: Until the results of ongoing trials are known, it is reasonable to favor the use of niacin and bile acid sequestrants in combination with statins, based on safety and efficacy with regard to effects on lipoproteins, atherosclerotic lesions, and, to a limited extent, clinical outcomes. The effect of ezetimibe on carotid atherosclerosis is indeterminate, but ezetimibe can be reasonably added to statin therapy as a secondary option for LDL-lowering. |
| | |
Authors:
|
John R Guyton |
Related Documents
:
|
12069577 - Selective uptake from ldl is stimulated by unsaturated fatty acids and modulated by cho... 21148477 - Dietary fat sensing via fatty acid oxidation in enterocytes - possible role in the cont... 10395027 - Enhancement of low density lipoprotein catabolism by non-steroidal anti-inflammatory dr... 9372477 - Regulation of plasma lipoprotein levels by dietary triglycerides enriched with differen... 17297227 - Manganese dioxide graphite composite electrodes: application to the electroanalysis of ... 7519007 - Lymphocytes possess an electrogenic h(+)-transporting pathway in their plasma membrane. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Current opinion in lipidology Volume: 21 ISSN: 1473-6535 ISO Abbreviation: Curr. Opin. Lipidol. Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-07-13 Completed Date: 2010-10-08 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9010000 Medline TA: Curr Opin Lipidol Country: England |
Other Details:
|
Languages: eng Pagination: 372-7 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. john.guyton@duke.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cardiovascular System / drug effects Drug Combinations Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects, pharmacology, therapeutic use* Intestines / drug effects* Lipoproteins, LDL / blood, metabolism* Niacin / adverse effects, pharmacology, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
0/Drug Combinations; 0/Hydroxymethylglutaryl-CoA Reductase Inhibitors; 0/Lipoproteins, LDL; 59-67-6/Niacin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Fibrates: no ACCORD on their use in the treatment of dyslipidaemia.
Next Document: Current world literature.